Health Condition 1: A00-B99- Certain infectious and parasitic diseases Health Condition 2: B342- Coronavirus infection, unspecified Health Condition 3: O- Medical and Surgical
Conditions
Interventions
Intervention1: Vardhmana Pippali: In group A, Pippali powder will be given ingradually in increasing and tapering dose for 30 days with Mrudwika Sharkara
Control Intervention1: Rehabilitation program
Sponsors
Institute of Teaching and Research in Ayurveda Institute of National Importance Ministry of Ayush
Eligibility
Inclusion criteria
Inclusion criteria: Patients having lingering symptoms of COVID 19 after testing negative for the disease and extending beyond three weeks from the onset of a first symptom (Acute COVID 19).
Exclusion criteria
Exclusion criteria: 1. Positive SARS-CoV-2 PCR at the screening visit 2. Patients having severe symptoms of Post COVID 19 syndrome with co-morbidities requiring hospitalization 3. History of any of the following in the past 14 days: fever > 38.2 degrees Celsius; new or worsening respiratory symptoms (e.g. cough, dyspnea) 4. Patients having uncontrolled cardiac, renal, hepatic disease, malignancy, AIDS, diabetes 5. Pregnant and lactating women 6. Patients taking phenytoin, propranolol, theophylline (as Pippali has moderate interaction with the absorption of these drugs) 7. Patients having or progressive towards serious sequelae such as thromboembolic complications 8. COVID-19 patients whose acute illness required intensive care 9. SpO2 10. Age below 18 years & above 60 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that the trial drugs will have immunomodulatory effect and thus will effective in the management Post COVID 19 SyndromeTimepoint: 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| The Vardhamana Pippali Rasayana will improve the quality of life in post COVID19 SyndromeTimepoint: 4 weeks | — |
Countries
India
Contacts
Public ContactDr Mandip Goyal
ITRA, jamnagar
Outcome results
None listed